RARa restrains CD8 T cell effector program [scRNA-seq]
ScRNA-seq for tumor-bearing  RARa-KO, or RARa-TG mice bearing MC38 tumors was performed. Overall design: T cells and other cells from WT, RARa-KO, or RARa-TG mice bearing MC38 tumors were compared on day 16 post tumor cell-injection.